2.6284
                                            Precedente Chiudi:
              $2.65
            Aprire:
              $2.57
            Volume 24 ore:
                12,115
            Relative Volume:
              0.39
            Capitalizzazione di mercato:
                $14.09M
            Reddito:
              -
            Utile/perdita netta:
              $-16.35M
            Rapporto P/E:
              -0.8618
            EPS:
                -3.05
            Flusso di cassa netto:
                $-11.88M
            1 W Prestazione:
              -4.42%
            1M Prestazione:
              -21.54%
            6M Prestazione:
                -21.31%
            1 anno Prestazione:
              -56.84%
            Lipocine Inc Stock (LPCN) Company Profile
Nome
                  
                      Lipocine Inc
                    
                Settore
                  Industria
                  Telefono
                  
                      801 994 7383
                    
                Indirizzo
                  
                      675 ARAPEEN DRIVE, SUITE 202, SALT LAKE CITY, UT
                    
                Confronta LPCN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                LPCN
                            
                             
                        Lipocine Inc 
                           | 
                    2.60 | 14.36M | 0 | -16.35M | -11.88M | -3.05 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.76 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    636.09 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    427.43 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    842.60 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    185.67 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Lipocine Inc Stock (LPCN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione | 
|---|---|---|---|
| 2021-06-24 | Iniziato | Cantor Fitzgerald | Overweight | 
| 2020-12-10 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy | 
| 2018-01-12 | Reiterato | H.C. Wainwright | Buy | 
| 2018-01-11 | Downgrade | Canaccord Genuity | Buy → Hold | 
| 2017-12-08 | Ripresa | H.C. Wainwright | Buy | 
| 2016-10-07 | Iniziato | H.C. Wainwright | Buy | 
| 2015-07-22 | Iniziato | ROTH Capital | Buy | 
| 2015-06-23 | Iniziato | Canaccord Genuity | Buy | 
                    Mostra tutto
                    
                  
                Lipocine Inc Borsa (LPCN) Ultime notizie
Lipocine (NASDAQ: LPCN) shows LPCN 2401 reduces liver fat at 12 weeks, MRI-PDFF data - Stock Titan
Will Lipocine Inc. stock outperform value stocksEarnings Beat & Accurate Technical Buy Alerts - newser.com
Lipocine Presents Promising LPCN 2401 Data at ObesityWeek - TipRanks
Lipocine Inc Presents LPCN 2401 Clinical Data at ObesityWeek® - TradingView
How Lipocine Inc. stock reacts to inflationary pressures2025 Technical Overview & Free Weekly Watchlist of Top Performers - newser.com
Will Lipocine Inc. stock go up soonGlobal Markets & Smart Swing Trading Alerts - newser.com
Lipocine Inc expected to post a loss of 54 cents a shareEarnings Preview - TradingView
How Lipocine Inc. stock performs after earningsJuly 2025 Price Swings & Expert Verified Movement Alerts - newser.com
Why analysts upgrade Lipocine Inc. stockJuly 2025 Decliners & Advanced Technical Analysis Signals - newser.com
Is Lipocine Inc. stock a safe buy before earningsJuly 2025 News Drivers & Free High Accuracy Swing Entry Alerts - newser.com
Is Lipocine Inc. stock trading near support levelsEarnings Risk Report & Consistent Return Strategy Ideas - newser.com
How to build a dashboard for Lipocine Inc. stockEarnings Overview Report & Free Technical Pattern Based Buy Signals - newser.com
Smart tools for monitoring Lipocine Inc.’s price actionJuly 2025 Opening Moves & Fast Moving Trade Plans - newser.com
Will a bounce in Lipocine Inc. offer an exitMarket Trend Summary & Free Expert Approved Momentum Trade Ideas - newser.com
Lipocine, Inc. Stock Plummets to New 52-Week Low of $2.57 - Markets Mojo
Is Lipocine Inc. stock attractive for long term wealth buildingWeekly Market Summary & Momentum Based Trading Ideas - newser.com
What margin trends mean for Lipocine Inc. stockJuly 2025 Trade Ideas & Capital Efficiency Focused Strategies - fcp.pa.gov.br
Is Lipocine Inc. stock dividend yield sustainableRecession Risk & Free Fast Entry Momentum Trade Alerts - Fundação Cultural do Pará
How risky is Lipocine Inc. stock now2025 Historical Comparison & Weekly Stock Performance Updates - fcp.pa.gov.br
Lipocine Inc Azioni (LPCN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
        Apri su Yahoo
        |
        Apri su Google
            |
            Aperto in Finviz
        |
        Apri in MarketWatch
            |
            Aperto a EDGAR    
        |
        Aperto su Reuters
    
    
                Capitalizzazione:
                 
                  | 
                Volume (24 ore):